retatrutide clinical trial sign up Phase 3: TRIUMPH Program Results 2026 Find Lilly Clinical Trials

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

Caution This is a hypothesis-generating study and should not be considered a study that answers a question

This weekly schedule is similar to other incretin-based medications used for obesity and metabolic health, making it more convenient than medications that require daily dosing

Your doctor is in the best position to know important factors that could impact symptoms, including your health history, your GLP-1 dosage, how long youve been taking it, and other medications you are taking, he says

The weight loss pattern continued, and participants lost an average of 14.9% of their body weight after 68 weeks

The system was equilibrated with 10 mM PBS at a flow rate of 20 l min 1 to achieve a stable baseline